Positions
- Professor
-
Pediatrics-Oncology
Baylor College of Medicine
Houston, TX, US
Currently employed by Baylor College of Medicine, Department of Pediatrics
- Medicine
-
Dan L Duncan Comprehensive Cancer Center
Baylor. College of Medicine
Houston, Texas, United States
Addresses
- Office Address (Office)
-
TCH-Clinical Care Center 6701 Fannin St.
Room: TXCL-151010
Houston, TX, 77030
United States
Phone: (832) 822-4208
klmcclai@txch.org
- Clinic (Clinic)
-
6701 Fannin St.
Suite 1400
Houston, TX, 77030
United States
Phone: (832) 822-4866
klmcclai@txch.org
Education
- Clinical Fellowship at University Of Minnesota Affiliate Hospitals
- 07/1981 - Minneapolis, Minnesota, United States
- Pediatric Hematology/Oncology
- Post-Doctoral Fellowship at National Institutes Of Health
- 06/1979 - Bethesda, Maryland, United States
- Molecular Biology
- Residency at Johns Hopkins Hospital
- 06/1976 - Baltimore, Maryland, United States
- Pediatrics
- MD from University Of Chicago Hospitals
- 06/1973 - Chicago, Illinois, United States
- Medicine
- PhD from University Of Chicago
- 06/1972 - Chicago, Illinois, United States
- Pathology/Virology
- BA from Augustana College
- 06/1967 - Sioux Falls, South Dakota, United States
- Chemistry/Biology
Certifications
- Medical License
- #H-1145 (06/01/2013 - 05/31/2021)
- State of Texas
- Texas Controlled Substances Registration Certificate
- #R0064025 (05/03/2014 - 05/31/2015)
- State of Texas
- As of 2017 the Texas Medical Board no longer required a Department of Public Safety controlled substances registration permit. The national DEA certificate is valid
- DEA Registration
- #AM9026047 (12/10/2019 - 01/31/2023)
- Drug Enforcement Adm., U.S. Dpt of Justice
- Board Certification in Pediatric Hematology/Oncology
- #620
- American Board of Pediatrics
- Re-certification not required per regulations in 1982.
- Board Certification in Pediatrics
- #23003
- American Board of Pediatrics
- Board Certification in General Pediatrics
Professional Interests
- Histiocytic Diseases
- Lymphomas
Professional Statement
My goal is to provide the highest quality of care to my patients by using the most current medical information available and with careful attention to their emotional as well as physical needs. I will always inform the patients and families of critical information so they can better understand how their health problem is being solved.
Selected Publications
-
Rogers BB, Browning I, Rosenblatt H, McClain K, Kemp J, Glasser LL, Gresik MV, Sumaya C, Wagner ML, Pollack MS. " A familial lymphoproliferative disorder presenting with primary pulmonary manifestations. " Am. Rev. Respir. Dis.. 1992 Jan ; 145 (1) : 203-8.
Pubmed PMID: 1309966. -
McClain KL, Kozinetz CA. " A phase II trial using thalidomide for Langerhans cell histiocytosis. " Pediatr Blood Cancer. 2007 Jan ; 48 (1) : 44-9.
Pubmed PMID: 16333818. -
Mahoney DH, McClain KL, Hanson IC, Taylor LD, Steuber CP. " Acquired immune deficiency, myelodysplasia, and acute nonlymphocytic leukemia associated with monosomy 7 and t(3;3) (q21;q26) in a child with Langerhans cell histiocytosis. " Am J Pediatr Hematol Oncol. 1989 ; 11 (2) : 153-7.
Pubmed PMID: 2546462. -
McClain K, Wilkowski C. " Activation of endogenous retroviral sequences in human leukemia. " Biochem. Biophys. Res. Commun.. 1985 Dec 31; 133 (3) : 945-50.
Pubmed PMID: 3002378.
Memberships
- American Society for Hematology
- Member
- American Society for Pediatric Hematology/Oncology
- Member
- Histiocyte Society
- Past President
- Texas Medical Association
- Member
- Society for Pediatric Research
- Member
- Children's Oncology Group
- Member
- Dan L Duncan Comprehensive Cancer Center
- Member (05/2015)
Funding
-
Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying Biomarkers for Early Detection and Risk Assessment
#RO1 CA154489-01) - $1,950,000.00 (04/01/2011 - 03/31/2016)
- Grant funding from NIH
Languages
Spanish
Log In to edit your profile